South Korea approves Pfizer’s coronavirus pill for emergency use.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
South Korea’s SK Bioscience has been given the all-clear to start a phase 3 trial of its COVID-19 vaccine GBP510 that will compare the shot […]
Shots: The NDA is based on STORM and SADAL studies. The P-IIb STORM study involves assessing of ATG-010 + low-dose dexamethasone in patients with rrMM […]
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started […]
Hanmi will retain options for the drug, efinopegdutide, in Korea under the deal, in which Merck is paying the Seoul-based company $10 million upfront and […]
Shots: The P-I study follows positive pre-clinical results and the Korean MFDS’ IND approval. The study will enroll ~32 healthy volunteers in collaboration with Chungnam […]
Copyright © 2024 | WordPress Theme by MH Themes